Home / Inspections / 1131811

FDA Inspection 1131811 — Abel Murillo, MD

Abel Murillo, MD — FEI 3017173067

The FDA completed an inspection of Abel Murillo, MD on Oct 13, 2020 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 13, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.